Aug 6, 2026 05:38PM
Aug 6, 2026 04:00PM
Jul 31, 2026 07:00AM
May 7, 2026 05:13PM
May 7, 2026 04:00PM
Apr 30, 2026 08:00AM
Mar 30, 2026 04:00PM INmune Bio reports 2025 financial results, plans regulatory filings
Mar 30, 2026 04:00PM
Mar 24, 2026 08:00AM
Oct 30, 2025 04:23PM
Oct 30, 2025 04:05PM
Oct 23, 2025 07:00AM
Aug 7, 2025 05:44PM
Aug 7, 2025 04:06PM INmune Bio reports $24.5M net loss, announces leadership changes
Aug 7, 2025 04:05PM
Jul 31, 2025 07:00AM
May 8, 2025 04:14PM
May 8, 2025 04:10PM
May 5, 2025 07:00AM
Mar 27, 2025 04:05PM
Mar 24, 2025 08:00AM INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
Oct 31, 2024 04:12PM
Oct 31, 2024 04:05PM
Oct 24, 2024 09:30AM
Aug 1, 2024 04:51PM
Aug 1, 2024 04:05PM
Jul 25, 2024 08:00AM
May 9, 2024 05:51PM INmune Bio, Inc. (INMB) Misses Q1 EPS by 8c
May 9, 2024 04:05PM
May 7, 2024 08:00AM
Mar 28, 2024 04:01PM
Mar 26, 2024 04:01PM
Nov 1, 2023 04:12PM
Nov 1, 2023 04:10PM
Oct 16, 2023 09:00AM INmune Bio Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Wednesday, November 1
Aug 7, 2023 04:42PM
Aug 7, 2023 04:00PM
Jul 31, 2023 08:00AM
May 3, 2023 04:51PM
May 3, 2023 04:10PM
Apr 24, 2023 09:00AM
Apr 24, 2023 09:00AM INmune Bio, Inc. to Report First Quarter 2023 Financial Results and Provide a Corporate Update on Wednesday, May 3
Mar 2, 2023 04:05PM
Nov 2, 2022 04:00PM
Oct 26, 2022 08:10AM
Oct 26, 2022 08:10AM
Aug 3, 2022 04:10PM
Jul 27, 2022 08:00AM
Jul 27, 2022 08:00AM INmune Bio, Inc. to Report Second Quarter 2022 Financial Results and Provide a Corporate Update on Wednesday, August 3
May 24, 2022 09:14AM

1,216,956 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All